{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:54:05Z","timestamp":1786974845204,"version":"build-2736575974"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To describe a rare phenotype of birdshot chorioretinitis (BSCR) characterised by diffuse retinal depigmentation and to evaluate its relationship with disease chronicity and visual outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This observational study included patients from the CO-BIRD cohort with ultra-widefield fundus imaging. Retinal depigmentation was graded using the albinism scale by Kruijt et al. (grades 0\u20133). Eyes with a grade\u2009\u2265\u20092 in at least one image were included. Disease activity and severity were assessed using best-corrected visual acuity (BCVA), vision-related quality of life (VFQ-25), visual field testing and multimodal imaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1016 eyes (508 patients), 52 eyes (26 patients, 5.1%) had depigmentation grade\u2009\u2265\u20092; 22 eyes (2.2%) reached grade 3. Fifteen years after symptom onset, BCVA worse than 0.7 logMAR occurred in 42.1% of grade 3 versus 5.0% of grade 2 eyes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.014). VFQ-25 scores were similarly reduced in both groups. Grade 3 was associated with a lower risk of optic disc oedema (HR\u2009=\u20090.38;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028) and a non-significant reduction in macular oedema risk. Choroidal neovascularisation occurred only in grade 3 (40.9%). Grade 3 was linked to worse BCVA (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.012), higher pattern standard deviation (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), and a history of active disease. Compared with previously published CO-BIRD data, grade 3 showed faster BCVA decline (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.044) and greater cumulative loss (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Diffuse retinal depigmentation resembling albinism is an uncommon but severe expression of BSCR, indicative of chronic disease and associated with poorer visual outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41433-026-04335-1","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:30:07Z","timestamp":1772703007000},"page":"1162-1168","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pigment loss and pseudo-albinism in Birdshot chorioretinitis"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-7814","authenticated-orcid":false,"given":"Ali\u00e9nor","family":"Vienne-Jumeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5614-8907","authenticated-orcid":false,"given":"Caroline","family":"Memmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souhila","family":"Kecili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Loeliger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Monnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8461-3119","authenticated-orcid":false,"given":"Antoine P.","family":"Br\u00e9zin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,5]]},"reference":[{"key":"4335_CR1","doi-asserted-by":"publisher","first-page":"4772","DOI":"10.3390\/jcm11164772","volume":"11","author":"E Bousquet","year":"2022","unstructured":"Bousquet E, Duraffour P, Debillon L, Somisetty S, Monnet D, Br\u00e9zin AP. Birdshot chorioretinopathy: a review. J Clin Med. 2022;11:4772.","journal-title":"J Clin Med"},{"key":"4335_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.62.14.3","volume":"62","author":"S Gelfman","year":"2021","unstructured":"Gelfman S, Monnet D, Ligocki AJ, Tabary T, Moscati A, Bai X, et al. ERAP1, ERAP2, and two copies of HLA-Aw19 alleles increase the risk for birdshot chorioretinopathy in HLA-A29 carriers. Investig Ophthalmol Vis Sci. 2021;62:3.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4335_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ajo.2021.03.059","volume":"228","author":"Standardization of Uveitis Nomenclature (SUN) Working Group","year":"2021","unstructured":"Standardization of Uveitis Nomenclature (SUN) Working Group. Classification criteria for birdshot chorioretinitis. Am J Ophthalmol. 2021;228:65\u201371.","journal-title":"Am J Ophthalmol"},{"key":"4335_CR4","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ajo.2005.08.067","volume":"141","author":"D Monnet","year":"2006","unstructured":"Monnet D, Br\u00e9zin AP, Holland GN, Yu F, Mahr A, Gordon LK, et al. Longitudinal cohort study of patients with birdshot chorioretinopathy. I. Baseline clinical characteristics. Am J Ophthalmol. 2006;141:135\u201342.","journal-title":"Am J Ophthalmol"},{"key":"4335_CR5","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1016\/S0161-6420(99)90403-7","volume":"106","author":"C Fardeau","year":"1999","unstructured":"Fardeau C, Herbort CP, Kullmann N, Quentel G, LeHoang P. Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology. 1999;106:1928\u201334.","journal-title":"Ophthalmology"},{"key":"4335_CR6","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.ophtha.2004.12.036","volume":"112","author":"S Kiss","year":"2005","unstructured":"Kiss S, Ahmed M, Letko E, Foster CS. Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy. Ophthalmology. 2005;112:1066\u201371.","journal-title":"Ophthalmology"},{"key":"4335_CR7","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1016\/j.ophtha.2018.08.003","volume":"125","author":"CC Kruijt","year":"2018","unstructured":"Kruijt CC, de Wit GC, Bergen AA, Florijn RJ, Schalij-Delfos NE, van Genderen MM. The phenotypic spectrum of albinism. Ophthalmology. 2018;125:1953\u201360.","journal-title":"Ophthalmology"},{"key":"4335_CR8","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0161-6420(88)33152-0","volume":"95","author":"CG Summers","year":"1988","unstructured":"Summers CG, Knobloch WH, Witkop CJ, King RA. Hermansky-Pudlak syndrome. Ophthalmic findings. Ophthalmology. 1988;95:545\u201354.","journal-title":"Ophthalmology"},{"key":"4335_CR9","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1136\/bjo-2023-324636","volume":"108","author":"J Loeliger","year":"2024","unstructured":"Loeliger J, Monnet D, Thorne J, Imikerene L, Kecili S, Br\u00e9zin AP. Visual acuity and visual field as a function of disease duration in patients with birdshot chorioretinitis. Br J Ophthalmol. 2024;108:1543\u20137.","journal-title":"Br J Ophthalmol"},{"key":"4335_CR10","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3928\/23258160-20160419-08","volume":"47","author":"JG Shantha","year":"2016","unstructured":"Shantha JG, Ho VY, Patel P, Forooghian F, Yeh S. Choroidal neovascularization associated with birdshot chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina. 2016;47:450\u20137.","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"4335_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1080\/09273948.2023.2215322","volume":"32","author":"L Debillon","year":"2024","unstructured":"Debillon L, Thorne JE, Bousquet E, Duraffour P, Kecili S, Monnet D, et al. Birdshot chorioretinitis in patients aged 80 and older. Ocul Immunol Inflamm. 2024;32:1212\u20137.","journal-title":"Ocul Immunol Inflamm"},{"key":"4335_CR12","doi-asserted-by":"publisher","first-page":"599558","DOI":"10.3389\/fimmu.2020.599558","volume":"11","author":"JJW Kuiper","year":"2020","unstructured":"Kuiper JJW, Venema WJ. HLA-A29 and Birdshot uveitis: further down the rabbit hole. Front Immunol. 2020;11:599558.","journal-title":"Front Immunol"},{"key":"4335_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.preteyeres.2014.11.003","volume":"44","author":"J Kuiper","year":"2015","unstructured":"Kuiper J, Rothova A, de Boer J, Radstake T. The immunopathogenesis of birdshot chorioretinopathy: a bird of many feathers. Prog Retin Eye Res. 2015;44:99\u2013110.","journal-title":"Prog Retin Eye Res"},{"key":"4335_CR14","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/eye.2012.10","volume":"26","author":"JS Pulido","year":"2012","unstructured":"Pulido JS, Canal I, Salom\u00e3o D, Kravitz D, Bradley E, Vile R. Histological findings of birdshot chorioretinopathy in an eye with ciliochoroidal melanoma. Eye. 2012;26:862\u20135.","journal-title":"Eye"},{"key":"4335_CR15","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/ICB.0000000000000367","volume":"11","author":"EH Sohn","year":"2017","unstructured":"Sohn EH, Chirco KR, Folk JC, Mullins RF. Clinicopathological correlation in a patient with previously treated birdshot chorioretinopathy. Retin Cases Brief Rep. 2017;11:344\u20137.","journal-title":"Retin Cases Brief Rep"},{"key":"4335_CR16","first-page":"5745","volume":"58","author":"L Hassman","year":"2017","unstructured":"Hassman L, Warren M, Huxlin KR, Chung MM, Lei XU. Evidence of melanoma immunoreactivity in patients with Birdshot retinochoroidopathy. Investig Ophthalmol Vis Sci. 2017;58:5745.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4335_CR17","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1038\/s41433-023-02425-y","volume":"37","author":"R Khalil","year":"2023","unstructured":"Khalil R, Petrushkin H, Rees A, Westcott M. The incidence, presenting clinical findings and treatment patterns of Birdshot Retinochoroiditis in a high-prevalence region: findings from Northern Ireland, England and Wales. Eye. 2023;37:2817\u201325.","journal-title":"Eye"},{"key":"4335_CR18","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.ajo.2007.08.011","volume":"144","author":"D Monnet","year":"2007","unstructured":"Monnet D, Levinson RD, Holland GN, Haddad L, Yu F, Br\u00e9zin AP. Longitudinal cohort study of patients with birdshot chorioretinopathy. III. Macular imaging at baseline. Am J Ophthalmol. 2007;144:818\u201328.","journal-title":"Am J Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04335-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04335-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04335-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T12:59:17Z","timestamp":1779368357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04335-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,5]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4335"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04335-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7482264\/v1","asserted-by":"object"}]},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,5]]},"assertion":[{"value":"28 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}